Logo image of ACB

AURORA CANNABIS INC (ACB) Stock Price, Quote, News and Overview

NASDAQ:ACB - Nasdaq - CA05156X8504 - Common Stock - Currency: USD

5.4499  +1.77 (+48.1%)

ACB Quote, Performance and Key Statistics

AURORA CANNABIS INC

NASDAQ:ACB (2/5/2025, 2:47:03 PM)

5.4499

+1.77 (+48.1%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High9.35
52 Week Low2.84
Market Cap299.09M
Shares54.88M
Float54.75M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)02-05 2025-02-05/bmo
IPO09-26 2007-09-26


ACB short term performance overview.The bars show the price performance of ACB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

ACB long term performance overview.The bars show the price performance of ACB in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ACB is 5.4499 USD. In the past month the price decreased by -21.7%. In the past year, price decreased by -15.27%.

AURORA CANNABIS INC / ACB Daily stock chart

ACB Latest News, Press Releases and Analysis

News Image
3 minutes ago - Chartmill

Here are the top movers in Wednesday's session.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

News Image
3 hours ago - Chartmill

What's going on in today's session

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

News Image
5 hours ago - Chartmill

The market is filled with gapping stocks in Wednesday's session.

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

News Image
7 hours ago - Chartmill

These stocks are moving in today's pre-market session

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

News Image
an hour ago - The Motley Fool

Aurora Cannabis (ACB) Q3 2025 Earnings Call Transcript

ACB earnings call for the period ending December 31, 2024.

ACB Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 83.04 801.72B
NVO NOVO-NORDISK A/S-SPONS ADR 29.21 382.65B
JNJ JOHNSON & JOHNSON 15.44 371.30B
MRK MERCK & CO. INC. 11.86 229.21B
NVS NOVARTIS AG-SPONSORED ADR 13.89 219.92B
AZN ASTRAZENECA PLC-SPONS ADR 18.61 219.91B
PFE PFIZER INC 8.52 150.23B
SNY SANOFI-ADR 13.57 134.72B
BMY BRISTOL-MYERS SQUIBB CO 51.43 122.04B
ZTS ZOETIS INC 30.53 79.33B
GSK GSK PLC-SPON ADR 9.14 77.20B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.16 42.48B

About ACB

Company Profile

ACB logo image Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. The company is headquartered in Leduc, Alberta and currently employs 1,073 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Company Info

AURORA CANNABIS INC

2207 90B Street Sw

Leduc ALBERTA T5J 1Y6 CA

CEO: Terry Booth

Employees: 1073

Company Website: https://www.auroramj.com/

Investor Relations: https://www.auroramj.com/investors/

Phone: 16043625207

ACB FAQ

What is the stock price of ACB?

The current stock price of ACB is 5.4499 USD.


What is the symbol for AURORA CANNABIS INC stock?

The exchange symbol of AURORA CANNABIS INC is ACB and it is listed on the Nasdaq exchange.


On which exchange is ACB stock listed?

ACB stock is listed on the Nasdaq exchange.


Is ACB a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ACB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ACB.


Does ACB stock pay dividends?

ACB does not pay a dividend.


When does ACB stock report earnings?

ACB will report earnings on 2025-02-05, before the market open.


What is the Price/Earnings (PE) ratio of ACB?

ACB does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.59).


What is the Short Interest ratio of ACB stock?

The outstanding short interest for ACB is 8.94% of its float.


ACB Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ACB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ACB. ACB may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACB Financial Highlights

Over the last trailing twelve months ACB reported a non-GAAP Earnings per Share(EPS) of -0.59. The EPS decreased by 27.43% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.4%
ROE -8.04%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%-2100%
Sales Q2Q%27.92%
EPS 1Y (TTM)27.43%
Revenue 1Y (TTM)12.17%

ACB Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 72% to ACB. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -9.1% and a revenue growth 17.55% for ACB


Ownership
Inst Owners13.37%
Ins Owners0.05%
Short Float %8.94%
Short Ratio6.8
Analysts
Analysts72
Price Target6.16 (13.03%)
EPS Next Y-9.1%
Revenue Next Year17.55%